[
    [
        {
            "time": "",
            "original_text": "医药行业2021年9月投资策略暨中报总结：政策预期基线变化中消化估值",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "中报总结",
                    "政策预期",
                    "估值"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药行业2021年9月投资策略暨中报总结：政策预期基线变化中消化估值",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 10,
                "Headline_Structure": 6,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "医疗服务行业周报：公立医院薪酬制度改革大幕拉开 不合理医疗费用将持续压缩",
            "features": {
                "keywords": [
                    "医疗服务",
                    "公立医院",
                    "薪酬制度",
                    "改革",
                    "医疗费用",
                    "压缩"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗服务"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医疗服务行业周报：公立医院薪酬制度改革大幕拉开 不合理医疗费用将持续压缩",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 10,
                "Headline_Structure": 5,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "【异动股】康龙化成(03759.HK)跌3.1%",
            "features": {
                "keywords": [
                    "康龙化成",
                    "异动股",
                    "下跌"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【异动股】康龙化成(03759.HK)跌3.1%",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 10,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "瑞银：予康龙化成(03759)“买入”评级 目标价升6.1%至240港元",
            "features": {
                "keywords": [
                    "瑞银",
                    "康龙化成",
                    "买入评级",
                    "目标价",
                    "上调"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "瑞银：予康龙化成(03759)“买入”评级 目标价升6.1%至240港元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 10,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "瑞银：上调康龙化成目标价至240港元，评级买入",
            "features": {
                "keywords": [
                    "瑞银",
                    "康龙化成",
                    "目标价",
                    "上调",
                    "买入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "瑞银：上调康龙化成目标价至240港元，评级买入",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 10,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]